PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » Schizophrenia

Psychiatric Times. Vol. 25 No. 3
Pages: 1  2  
Next
 

Negative Symptoms in Schizophrenia: The Importance of Identification and Treatment

By Dawn I. Velligan, PhD and Larry D. Alphs, PhD | March 1, 2008
Dr Velligan is professor and codirector of the Division of Schizophrenia and Related Disorders in the department of psychiatry at the University of Texas Health Science Center at San Antonio. Dr Alphs is therapeutic area leader in psychiatry, Medical and Scientific Affairs, for Janssen, LP, Ortho-McNeil Janssen Scientific Affairs, LLC, Titusville, NJ. Dr Velligan reports that she has the following relationships: AstraZeneca: consultant, travel expenses, honoraria, research grant, Speakers' Bureau, and advisory board; Bristol-Myers Squibb: consultant, honoraria, and research grant; Janssen: consultant, honoraria, research grant, Speakers' Bureau, and advisory board; Pfizer: consultant, honoraria, research grant, and Speakers' Bureau; and Organon: consultant, advisory board, and research grant. Dr Alphs reports that he is employed by Ortho-McNeil Janssen.

More Like This

Schizophrenia: Some Neglected Topics

Psychological Therapies for Schizophrenia: Family and Cognitive Interventions

New Findings in Early-Onset Schizophrenia

Treatment Challenges in Schizophrenia: A Multifaceted Approach to Relapse Prevention

Complementary Therapies for Schizophrenia: Expanding the Clinician’s Toolbox

More > >

Schizophrenia is among the top 10 disabling conditions worldwide for young adults.1,2 In the United States, the cost of treatment and loss in productivity associated with schizophrenia are estimated to be as high as $60 billion annually.3-5 More than three quarters of this amount is associated with loss in productivity.1 Patients with schizophrenia struggle with many functional impairments, including performance of independent living skills, social functioning, and occupational/educational performance and attainment.6 Most patients require some public assistance for support, and only 10% to 20% of patients are able to sustain full- or part-time competitive employment.7-9 Improving functional outcomes for these individuals is a significant mental health priority.

Research suggests that the negative symptoms of schizophrenia, including problems with motivation, social withdrawal, diminished affective responsiveness, speech, and movement, contribute more to poor functional outcomes and quality of life for individuals with schizophrenia than do positive symptoms.10-16 Moreover, caregivers of patients with negative symptoms report high levels of burden.17 Negative symptoms tend to persist longer than positive symptoms and are more difficult to treat.15,18 Research suggests that improvements in negative symptoms are associated with a variety of improved functional outcomes including independent living skills, social functioning, and role functioning.19 Targeting negative symptoms in the treatment of schizophrenia may have significant functional benefits. Treatment of negative symptoms has been identified as a vital unmet clinical need for many persons with schizophrenia.15,18

Current antipsychotic treatments primarily address the positive symptoms of the disorder.15,18,20 In brief medication visits, physicians typically assess issues related to delusions, hallucinations, disorganized and aggressive behavior, and hostility. These are common symptoms that may cause individuals to be hospitalized, go to emergency departments, seek out crisis services, or come to the attention of the criminal justice system. Physicians may not be aware of the extent of negative symptoms, may not know how to assess these symptoms, may be unclear about the impact of treatments on negative symptoms, and may be unfamiliar with treatment strategies that may favorably impact negative symptoms. In this article, we describe the nature of negative symptoms, some of the etiological factors that contribute to a negative symptom presentation, and ways of addressing negative symptoms.

What are negative symptoms?

Negative symptoms represent a reduction of emotional responsiveness, motivation, socialization, speech, and movement. Primary negative symptoms are etiologically related to the core pathophysiology of schizophrenia whereas secondary negative symptoms are derivative of other symptoms of schizophrenia, other disease processes, medications, or environment.15,21 For example, antipsychotic medications can produce akinesia or blunted affect. Depression can cause anhedonia, lack of motivation, and social withdrawal. Lack of stimulation in impoverished institutional environments can lead to complacency and problems with motivation and initiation. Negative symptoms can also be the result of psychotic processes.15,21 For example, social withdrawal can be caused by paranoia or by immersion in the psychotic process to the exclusion of real-life relationships. Primary and enduring negative symptoms are often referred to as the "deficit syndrome."22 Individuals with the deficit syndrome have been found to have greater cognitive deficits and poorer outcomes than patients who do not have this syndrome.22

The face of negative symptoms

The brief narrative presents a description of a typical day of a patient with schizophrenia. As will be apparent, the patient demonstrates several classic negative symptoms, including blunted emotional responsiveness. "Jesse" produces very little speech and needs to be repeatedly prompted by the interviewer. He spends his days without much physical activity, mostly watching television. He has no friends and is visited by his father once a week. His interests are restricted to watching television and smoking. While he states that he likes basketball, he does not play or watch basketball. Emotional responsiveness was blunted in the interview even with attempts to elicit it. Interviews with family members revealed that Jesse has exhibited these behaviors for many years. When asked, Jesse states that he wants to get a job, but he has done nothing to find a job in more than a decade.

Individuals like Jesse are often seen for brief medication visits. Because there are no obvious positive symptoms and no problems with acting out or hostility, few changes in medication may be initiated. There may be little questioning on the part of the treating physician to determine the quality of Jesse's life or manner in which he spends his time. Some of the reluctance to get into such issues has to do with the limited time public-sector physicians may be able to spend with each patient. In most clinicians' minds, patients with pressing needs, such as suicidal or aggressive behaviors or severe symptom exacerbations, need more immediate attention. Moreover, the symptoms embodied in the negative syndrome may not be considered an important domain for treatment by either the physician or the patient. Note that Jesse does not identify anything about his life as a "chief complaint." His family seems to accept these symptoms, and for the most part, society has not targeted them as an unmet health care need. There may also be a perception among physicians that little can be done for negative symptoms even if they are identified.

How to assess negative symptoms

Individuals with schizophrenia are often unaware of the extent of their negative symptoms.23 They frequently do not spontaneously report negative symptoms as problems and are less concerned about them than their relatives may be.17 Family members may complain of a lack of an emotional connection with their son or daughter and state that the individual is not involved in life, but they do not aggressively seek treatment for these symptoms. Physicians or physician extenders will usually not get information about negative symptoms unless they have time to observe and to ask about specific behaviors. Furthermore, if symptoms are identified, there are no generally recognized approaches to treatment or well-established clinical assessment tools to measure treatment progress or failure.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by E S | December 20, 2010 2:30 AM EST

What about delusional thinking? Haven't you found that it quiets the paranoia which makes life an impossiblity.

by shirley jensen | December 17, 2010 12:43 PM EST

In my observations of my son who has been actively "medicated"for over 20 years, the negative symptoms are a result of the drugs themselves.  He is now in the process of being taken off antipsychotics and antidepressants, and is slowly improving, at least in what is called the "negative" symptoms which continued to get worse and worse over the years.  PS.  The neuroleptics didn't help the voices either.  Hope you pay attention to this and pass it on.  Of course, this is already known but ignored.....





  • Goff DC, Lamberti JS, Leon AC, et al. A placebo-controlled add-on trial of the ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology. 2007 May 9; [Epub ahead of print].
  • Velligan DI, Prihoda TJ, Ritch JL, et al. A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients. Schizophr Bull. 2002;28: 283-292.


 
RELATED TOPICS

Disorganized schizophrenia
Paranoid schizophrenia
Childhood schizophrenia
Catatonic schizophrenia
Schizophrenia and disorders with psychotic features
Schizotypal personality disorder


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 

 
FROM PHYSICIANS PRACTICE
Tax Schemes Every Physician Should Avoid
Ike Devji, JD, January 31, 2012
The next 60 days marks the final push to sell physicians across the United States tax plans of both good and questionable value.
Boosting Collections at Your Medical Practice: Whose Job Is It?
P.J. Cloud-Moulds, January 28, 2012
Embrace the relationship between your billing company and your medical practice staff.
Managing Difficult Medical Practice Employees
Shelly K. Schwartz, January 27, 2012
Tips for transforming immature staff members into great employees.
Prevent Physician Distraction When Using mHealth Technology
Aubrey Westgate, January 25, 2012
As more and more physicians use handheld mobile technology in their day-to-day work, some critics are raising concerns about “distracted doctoring.”
Can That Applicant Do the Job at Your Medical Practice?
Karen Zupko, January 25, 2012
If like many communities, yours has significant numbers of non-English speaking people with whom neither you nor your staff are able to converse, your practice is at a serious disadvantage.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Pathological Lying: Symptom or Disease?
  • Psychopathy and Antisocial Personality Disorder: A Case of Diagnostic Confusion
  • Does Marijuana Withdrawal Syndrome Exist?
  • The Hidden Suffering of the Psychopath
  • The Cannabis-Psychosis Link
  • Broken Sleep May Be Natural Sleep
  • Sleep Hygiene
  • The Cannabis-Psychosis Link
  • How Psychotherapy Changes the Brain
  • Psychiatric Pharmacogenomics
  • Whatever Happened to Speculative Thought? Some Historical Evidence Against Evidence-Based Medicine
  • Twenty Meditations For Residents
  • Sleep Hygiene: Tips on Getting a Restful Night's Sleep
  • Integrative Mental Health Resource Launched
  • APA Should Delay Publication Of DSM-5
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • What's Your Challenge?
  • APA Should Delay Publication Of DSM-5
  • Borderline Personality Disorder and Bipolar Disorder—Distinguishing Features of Clinical Diagnosis and Treatment
  • Grief, Mourning—and the Denial of Death
  • Occupy Medicine: Reclaiming Our Lost Leadership
  • What's Your Challenge?
  • Integrative Mental Health Resource Launched
  • What Citalopram Tells Us About Prescribing Practices
  • Tales from the New Asylum: Slow Poison
  • Improving Suicide Risk Assessment
Click here to subscribe to our newsletter
 
CAREER CENTER

  • Featured Jobs
  • Resources
  • State Listings
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
  • Arizona
  • California
  • Florida
  • Massachusetts
  • New Jersey
Virtual Career Expo: On Demand


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Schizophrenia
Evidence on Schizophrenia
Guidelines on Schizophrenia
Patient Education on Schizophrenia
Clinical Trials on Schizophrenia
Practical Articles on Schizophrenia
Research and Reviews on Schizophrenia
All "Schizophrenia" results

CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy